Reported 8 months ago
Three Motley Fool contributors recommend AstraZeneca (NASDAQ: AZN), Bristol Myers Squibb (NYSE: BMY), and Pfizer (NYSE: PFE) as no-brainer healthcare stocks to buy for under $100. AstraZeneca is seen as a growth opportunity with a modest valuation and ambitious growth targets. Bristol Myers Squibb, despite challenges from patent cliffs, showcases promising revenue growth from newer assets. Pfizer stands out with a low share price, attractive valuation, growing product pipeline, and a substantial dividend yield, making it a compelling investment choice.
Source: YAHOO